157 related articles for article (PubMed ID: 37168335)
1. Xihuang pill induces pyroptosis and inhibits progression of breast cancer cells via activating the cAMP/PKA signalling pathway.
Chen C; Yuan S; Chen X; Xie J; Wei Z
Am J Cancer Res; 2023; 13(4):1347-1362. PubMed ID: 37168335
[TBL] [Abstract][Full Text] [Related]
2. Xihuang pills induce apoptosis in hepatocellular carcinoma by suppressing phosphoinositide 3-kinase/protein kinase-B/mechanistic target of rapamycin pathway.
Teng YJ; Deng Z; Ouyang ZG; Zhou Q; Mei S; Fan XX; Wu YR; Long HP; Fang LY; Yin DL; Zhang BY; Guo YM; Zhu WH; Huang Z; Zheng P; Ning DM; Tian XF
World J Gastrointest Oncol; 2022 Apr; 14(4):872-886. PubMed ID: 35582102
[TBL] [Abstract][Full Text] [Related]
3. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
[No Abstract] [Full Text] [Related]
4. Xihuang pill facilitates glioma cell pyroptosis via the POU4F1/STAT3 axis.
Tang N; Zhu Y; Yu J
Funct Integr Genomics; 2023 Nov; 23(4):334. PubMed ID: 37962640
[TBL] [Abstract][Full Text] [Related]
5. Exploring the Regulation Mechanism of Xihuang Pill,
Yang K; Zeng L; Ge A; Bao T; Xu T; Xie X; Liu L
Front Pharmacol; 2020; 11():825. PubMed ID: 32595497
[TBL] [Abstract][Full Text] [Related]
6. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.
Su L; Jiang Y; Xu Y; Li X; Gao W; Xu C; Zeng C; Song J; Weng W; Liang W
Biomed Pharmacother; 2018 Jun; 102():1111-1119. PubMed ID: 29710529
[TBL] [Abstract][Full Text] [Related]
7. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
[TBL] [Abstract][Full Text] [Related]
8. Xihuang Pill-destabilized CD133/EGFR/Akt/mTOR cascade reduces stemness enrichment of glioblastoma via the down-regulation of SOX2.
Xu L; Duan H; Zou Y; Wang J; Liu H; Wang W; Zhu X; Chen J; Zhu C; Yin Z; Zhao X; Wang Q
Phytomedicine; 2023 Jun; 114():154764. PubMed ID: 36963368
[TBL] [Abstract][Full Text] [Related]
9. The Antitumor Effect of Xihuang Pill on Treg Cells Decreased in Tumor Microenvironment of 4T1 Breast Tumor-Bearing Mice by PI3K/AKT~AP-1 Signaling Pathway.
Li XY; Su L; Jiang YM; Gao WB; Xu CW; Zeng CQ; Song J; Xu Y; Weng WC; Liang WB
Evid Based Complement Alternat Med; 2018; 2018():6714829. PubMed ID: 29849718
[TBL] [Abstract][Full Text] [Related]
10. Xihuang Pill Induces Apoptosis of Human Glioblastoma U-87 MG Cells via Targeting ROS-Mediated Akt/mTOR/FOXO1 Pathway.
Shao M; He Z; Yin Z; Ma P; Xiao Q; Song Y; Huang Z; Ma Y; Qiu Y; Zhao A; Zhou T; Wang Q
Evid Based Complement Alternat Med; 2018; 2018():6049498. PubMed ID: 30046342
[TBL] [Abstract][Full Text] [Related]
11. Systems pharmacology in combination with proteomics reveals underlying mechanisms of Xihuang pill against triple-negative breast cancer.
Xu X; Zhang J; Zhang Z; Wang M; Liu Y; Li X
Bioengineered; 2020 Dec; 11(1):1170-1188. PubMed ID: 33092442
[TBL] [Abstract][Full Text] [Related]
12. Anti-breast cancer effects and mechanisms of Xihuang pill on human breast cancer cell lines.
Pan G; Wang W; Wang L; Zhang F; Yin X; Wang J; Liang R
J Tradit Chin Med; 2013 Dec; 33(6):770-8. PubMed ID: 24660610
[TBL] [Abstract][Full Text] [Related]
13. Network Pharmacology-Oriented Identification of Key Proteins and Signaling Pathways Targeted by Xihuang Pill in the Treatment of Breast Cancer.
Wu J; Luo D; Li S
Breast Cancer (Dove Med Press); 2020; 12():267-277. PubMed ID: 33324095
[TBL] [Abstract][Full Text] [Related]
14. Metabolomics-based discovery of XHP as a CYP3A4 inhibitor against pancreatic cancer.
Yang Y; Guo Y; Luo H; Wang M; Chen F; Cui H; Chen P; Yin Z; Li L; Dai Y; Zeng J; Zhao J
Front Pharmacol; 2023; 14():1164827. PubMed ID: 37081969
[No Abstract] [Full Text] [Related]
15. Guidelines for the clinical application of the
Tang H; Lu Q; Feng S; Xiao Z; Wu W; Chen G; Deng L; Yu T; Wu J; Lin H; Ji B; Lin J; Zhang C; Li L; Liu T; Ouyang Y; Lei K; Chen J; Peng W; Qiu Z; Cai Q; Liang Q; Liu C; Li Y; Zhu L; Zhang Z; Liu X; Lin L; Zheng Z
Pharm Biol; 2024 Dec; 62(1):472-479. PubMed ID: 38769628
[TBL] [Abstract][Full Text] [Related]
16. GLP1R inhibits the progression of endometrial carcinoma through activation of cAMP/PKA pathway.
Li W; Gu Y; Liu S; Ruan F; Lv W
J Clin Lab Anal; 2022 Oct; 36(10):e24604. PubMed ID: 35989517
[TBL] [Abstract][Full Text] [Related]
17. LINC01121 Inhibits Cell Apoptosis While Facilitating Proliferation, Migration, and Invasion Though Negative Regulation of the Camp/PKA Signaling Pathway via GLP1R.
Qian YG; Ye Z; Chen HY; Lv Z; Zhang AB; Fan L; Zhou J; Zheng SS; Wang WL
Cell Physiol Biochem; 2018; 47(3):1007-1024. PubMed ID: 29843149
[TBL] [Abstract][Full Text] [Related]
18. Xihuang pill potentiates the anti-tumor effects of temozolomide in glioblastoma xenografts through the Akt/mTOR-dependent pathway.
Fu J; Zhu SH; Xu HB; Xu YQ; Wang X; Wang J; Kong PS
J Ethnopharmacol; 2020 Oct; 261():113071. PubMed ID: 32603676
[TBL] [Abstract][Full Text] [Related]
19. GNB4 Silencing Promotes Pyroptosis to Inhibit the Development of Glioma by Activating cGAS-STING Pathway.
Gao Z; Yang J
Mol Biotechnol; 2024 May; ():. PubMed ID: 38814382
[TBL] [Abstract][Full Text] [Related]
20. Antitumor effects of Xi Huang pills on MDA‑MB‑231 cells in vitro and in vivo.
Zheng W; Han S; Jiang S; He X; Li X; Ding H; Cao M; Li P
Mol Med Rep; 2018 Aug; 18(2):2068-2078. PubMed ID: 29956784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
